HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.
about
Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cellsProtein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomesKaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virusAn unusual presentation of Castleman's disease:a case reportMulticentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case reportUpdate and new approaches in the treatment of Castleman diseaseThe Role of Gammaherpesviruses in Cancer PathogenesisThe modulation of apoptosis by oncogenic virusesKSHV: pathways to tumorigenesis and persistent infectionKSHV Latency Locus Cooperates with Myc to Drive Lymphoma in MiceRole of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation.Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.Multimodality imaging and clinical features in Castleman disease: single institute experience in 30 patients.Progressive accumulation of activated ERK2 within highly stable ORF45-containing nuclear complexes promotes lytic gammaherpesvirus infectionDistinct roles for extracellular signal-regulated kinase 1 (ERK1) and ERK2 in the structure and production of a primate gammaherpesvirusKSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.Tpl2/AP-1 enhances murine gammaherpesvirus 68 lytic replication.Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma.A case of TAFRO syndrome with a large mediastinal mass treated with debulking surgeryCastleman's disease with TAFRO syndrome: a case report from SyriaMolecular biology of KSHV in relation to AIDS-associated oncogenesis.Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.Update on HHV-8-Associated MalignanciesEstablishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40.Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes.DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirusPathology of lymphoma in HIV.How do viruses trick B cells into becoming lymphomas?AIDS related systemic non-Hodgkin's lymphomaAn interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman diseaseKaposi's sarcoma herpesvirus upregulates Aurora A expression to promote p53 phosphorylation and ubiquitylationContribution of viral mimics of cellular genes to KSHV infection and disease.Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.HIV infection and lymphoma.Unraveling virus-induced lymphomagenesisRituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseRetroperitoneal laparoscopic management method of Castleman's disease in the adrenal gland: two cases report and review of the literatureIRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation.
P2860
Q24527215-EF62770F-8AD7-4604-B278-C37DD8E386E3Q24538878-12BB684E-608C-42C0-A741-D16620170E78Q24543014-795C441F-F8F1-4744-8592-1BB1C3ED19E3Q24670086-83342FBA-0E08-4F35-91DB-6AB598180B26Q24803650-B106ADF2-0AF8-4E2C-9894-928E2C97F74CQ24805204-0F4000D1-6081-4E1B-A529-8570F0D6525AQ26740703-7FCFAAA6-4BBA-4744-9386-BC6410E49CF4Q26767186-E4F7DC20-C473-4893-96E4-F23D0A6314A5Q26995410-67E951E8-AEAF-4721-A185-EAEB49D0F853Q27026000-D020BAEB-7B89-4E17-933E-80B5405AC3CCQ28547671-B1978E05-B7C1-4EA3-A3A1-83C5E4960B96Q30156825-3F09C48A-941D-4C16-A8EA-7AA9CBCB7233Q30311122-F8B8A4CA-3D1B-45F8-BAAC-A499DF70A3F5Q30384511-3DC67C9F-A195-47E5-A4A8-00A9B0DEA837Q30413848-B945DE46-1D14-436A-A366-5C60AE1CFAA5Q30422254-873EE409-7DC4-4F08-B77F-CF6412ED95A0Q30433391-D77D6E74-BA95-4250-BCCC-23EFCCA448D5Q30919407-8B6989D6-2466-4661-BDD8-A49C7259D895Q30982439-D7B9D2C2-5146-4966-9C39-A6511D75C9D5Q33433216-502FC3C6-EBB5-4EBB-B73B-8E78CFB219F5Q33442420-DA25E6B5-9697-44D8-AFEF-3E72263EC54FQ33560572-59BB7B3F-9EFF-4EC0-83E3-AA2512A239E0Q33772234-0762B04C-94AA-4866-A411-68FE92B4BA9DQ33814153-CF9DD25D-18AE-4587-B822-8B48D53139E0Q33834753-577DE299-E6C8-4D0B-97A5-E93E332EC1DEQ33851443-7D87D59B-9EDC-4ABF-967A-3D562805A0B2Q33853499-E3B88BA4-4160-49BD-8554-E8FC1C188FF2Q34020069-BF8253BE-28E2-43F8-A841-1306B37537D3Q34020096-D8C1DCA4-3C5B-45C3-960C-E33027B9FDFAQ34120667-57125E60-0196-4ADD-A82F-F5B1275A062DQ34157797-6C92625F-548C-4CCA-ACFB-79F8A85A23D9Q34186981-226689B3-CEC0-47E9-B7FC-28FFBFD86FF5Q34303583-F053FDA5-7A92-4707-8F5A-913F867849D9Q34350776-12B99DDC-88FF-4DD3-9175-83DCA9BFB167Q34569256-2966ACAB-DA99-42E6-B7EE-E7D96C39D90BQ34585452-E701BDBE-7421-47DD-B772-E4D75CE603ACQ34614553-7323E01B-F82D-49DE-8A17-5D9826FC426FQ34636851-134E459C-B9DB-4AB5-B00C-D98166BDD15EQ35017504-6E550180-32D8-4583-BD2F-3571E0FD555CQ35034278-FD9EB65D-8944-404C-8D2B-4E9E98D581D9
P2860
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
HHV-8 is associated with a pla ...... sitive plasmablastic lymphoma.
@ast
HHV-8 is associated with a pla ...... sitive plasmablastic lymphoma.
@en
type
label
HHV-8 is associated with a pla ...... sitive plasmablastic lymphoma.
@ast
HHV-8 is associated with a pla ...... sitive plasmablastic lymphoma.
@en
prefLabel
HHV-8 is associated with a pla ...... sitive plasmablastic lymphoma.
@ast
HHV-8 is associated with a pla ...... sitive plasmablastic lymphoma.
@en
P2093
P1433
P1476
HHV-8 is associated with a pla ...... sitive plasmablastic lymphoma.
@en
P2093
Isaacson PG
P304
P407
P577
2000-02-01T00:00:00Z